Mead Johnson Nutrition Company (NYSE:MJN) Reached the 52-Week High of $62.04
Mead Johnson Nutrition Company is a pediatric nutrition company. Mead Johnson Nutriti has a market cap of $12.69 billion; its shares were traded at around $62.04 with a P/E ratio of 26.4 and P/S ratio of 4.4. The dividend yield of Mead Johnson Nutriti stocks is 1.5%.
On October 28, Mead Johnson Nutrition Company reported results for the third quarter of 2010. Net sales for the quarter ended Sept. 30, 2010, totaled $810.2 million, up 16 percent from $699.8 million a year ago. Sales benefited 12 percent from volume, 3 percent from price and 1 percent from foreign exchange. Earnings before interest and income taxes (EBIT) for the third quarter totaled $165.5 million, up from $159.7 million a year earlier. Net earnings attributable to shareholders totaled $106.1 million, or $0.52 per diluted share, compared with $97.6 million, or $0.48 per diluted share for the prior-year quarter.
Mead Johnson Nutrition Company is in the portfolios of Daniel Loeb, Steve Mandel, Paul Tudor, Stanley Druckenmiller, Chris Shumway, David Winters, Chris Davis, Jim Simons, John Paulson, Mario Gabelli, Steven Cohen, Bruce Koyner, George Soros, Murray Stahl, Louis Moore Bacon, and Jeremy Grantham.
In August, Buy: Director James M Cornelius bought 10,000 shares of MJN stock.
Genzyme Corp. (GENZ) Reached the 52-Week High of $70.91
Genzyme Corporation is a global biotechnology company dedicated to making a major positive impact on the lives of people with serious diseases. Genzyme Corp. has a market cap of $18.07 billion; its shares were traded at around $70.91 with a P/E ratio of 78.8 and P/S ratio of 4. Genzyme Corp. had an annual average earning growth of 17.5% over the past 10 years. GuruFocus rated Genzyme Corp. the business predictability rank of 2.5-star.
On October 20, Genzyme Corp. reported results for the third quarter of 2010. Third-quarter revenue was $1.0 billion, compared with $923.8 million in the same period last year. Operating results for the third quarter of 2009 have been revised to exclude the Genetics and Diagnostics businesses, which the company is planning to divest by the end of this year. GAAP net income was $69.0 million, or $0.26 per diluted share, compared with $16.0 million, or $0.06 per diluted share, in the third quarter of 2009. Non-GAAP net income was $111.5 million, or $0.42 per diluted share, in line with the company’s guidance, compared with $77.9 million, or $0.28 per diluted share, in the same period last year.
Genzyme Corp. is in the portfolios of Carl Icahn, Steven Cohen, Michael Price, Edward Owens, Richard Perry, Chris Shumway, Eric Mindich, John Buckingham, Murray Stahl, John Paulson, Richard Perry, Louis Moore Bacon, Stanley Druckenmiller, Mario Gabelli, Jeremy Grantham, Jean-Marie Eveillard, Ruane Cunniff, and Kenneth Fisher.
In August, Sell: Corp Contrllr,ChiefAccntOfficr Jason Amello sold 6,640 shares of GENZ stock. Sell: Exe VP,President Int'l Group Sandford D Smith and Sell: SrVP,Chief Human Resources Off Zoltan A Csimma sold shares in July.Sell: Senior Vice President James A Geraghty sold 1,000 shares in June.
Xerox Corp. (NYSE:XRX) Reached the 52-Week High of $11.83
Xerox Corporation is The Document Company and a leader in the global document market, providing document solutions that enhance business productivity. Xerox Corp. has a market cap of $16.36 billion; its shares were traded at around $11.83 with a P/E ratio of 13.2 and P/S ratio of 1.1. The dividend yield of Xerox Corp. stocks is 1.5%. Xerox Corp. had an annual average earning growth of 0.5% over the past 10 years.
Xerox Corp. recently reported results for the third quarter of 2010. Third-quarter revenue of $5.4 billion was up 48 percent including a 2 point negative impact from currency. On a pro-forma basis, with ACS in the company’s 2009 results, total revenue grew 2 percent or 4 percent in constant currency. Revenue from technology, representing the sale of document systems, supplies, technical service and financing of products, was up 3 percent or 5 percent in constant currency. Total install activity for Xerox equipment was up 20 percent, reflecting strong demand across all product segments. Revenue from services was up 2 percent on a pro-forma basis including a 1 point negative impact from currency, and represents the company’s business process, IT and document outsourcing offerings.
Xerox Corp. is in the portfolios of Larry Robbins, David Einhorn, Robert Olstein, Chase Coleman, Dodge & Cox, Charles Brandes, James Barrow, David Williams, Bruce Koyner, Jeremy Grantham, George Soros, John Keeley, Mario Gabelli, David Dreman, Jean-Marie Eviellard, and Steven Cohen.
Last month, Sell: Vice President and Controller Leslie F Varon sold 20,000 shares of XRX stock. In October, Sell: Senior Vice President Willem T Appelo,Sell: Senior Vice President Russell Peacock,
Sell: Vice President James H Lesko, and Sell: Vice President Kevin M Warren sold shares..
BHP Billiton Ltd. (NYSE:BHP) Reached the 52-Week High of $88.67
BHP Billiton is a leader in the global natural resources industry. Bhp Billiton Ltd. has a market cap of $148.89 billion; its shares were traded at around $88.67 with and P/S ratio of 2.9. The dividend yield of Bhp Billiton Ltd. stocks is 2%.
BHP Billiton Ltd. is in the portfolios of Kenneth Fisher, David Dreman, RS Investment Management, John Buckingham, Murray Stahl, Mario Gabelli, Bruce Koyner, and Jim Simons.
Ford Motor Company (NYSE:F) Reached the 52-Week High of $16.8
Ford Motor Company produces cars and trucks. The company and its subsidiaries also engage in other businesses, including manufacturing automotive components and systems and financing and renting vehicles and equipment. Ford Motor Company has a market cap of $57.78 billion; its shares were traded at around $16.8 with a P/E ratio of 8.4 and P/S ratio of 0.5.
On October 26, Ford Motor Company reported third quarter net income of $1.7 billion, or 43 cents per share, a $690 million improvement from third quarter 2009. Excluding special items, Ford reported a pre-tax operating profit of $2.1 billion, or 48 cents per share, an improvement of $1.1 billion from a year ago. Ford has posted pre-tax operating profits for five consecutive quarters. Ford’s third quarter revenue was $29 billion, a decline of $1.3 billion from the same period a year ago. Excluding Volvo revenue from 2009, Ford’s revenue in the third quarter was up $1.7 billion compared with the same period a year ago.
Ford Motor Company is in the portfolios of Ken Heebner, Ronald Muhlenkamp, Jean-Marie Eviellard, Donald Smith, Bruce Koyner, Mario Gabelli, Jeremy Grantham, Ron Baron, George Soros, and Kenneth Fisher.
In November, Sell: Director Richard A Manoogian, Sell: Group Vice President James D Farley, Sell: Group Vice President Susan M Cischke, Sell: Vice President and Controller Robert L Shanks, and Sell: Group Vice President Bennie W. Fowler sold shares of F stock.